Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
暂无分享,去创建一个
[1] G. Multhaup,et al. Phosphorylation Regulates Intracellular Trafficking of β-Secretase* , 2001, The Journal of Biological Chemistry.
[2] E. Masliah,et al. Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions , 2010, The Journal of Neuroscience.
[3] F. Pedata,et al. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia , 2005, Neurochemistry International.
[4] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[6] M. Staufenbiel,et al. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.
[7] C. Haass,et al. Phosphorylation of the β-Amyloid Precursor Protein at the Cell Surface by Ectocasein Kinases 1 and 2* , 2000, Journal of Biological Chemistry.
[8] Hans-Ulrich Demuth,et al. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. , 2009, Biochemistry.
[9] E. Candelario-Jalil. A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation , 2009, Aging.
[10] E. Klann,et al. Mitochondrial superoxide: a key player in Alzheimer's disease , 2009, Aging.
[11] F. LaFerla. Pathways linking Abeta and tau pathologies. , 2010, Biochemical Society transactions.
[12] Khadija Iqbal,et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.
[13] K. Zou,et al. A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.
[14] Phillip B. Jones,et al. Mutations in amyloid precursor protein affect its interactions with presenilin/γ-secretase , 2009, Molecular and Cellular Neuroscience.
[15] B. Hyman,et al. Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy. , 2004, Journal of cell science.
[16] Sunney I Chan,et al. Tuning the conformation properties of a peptide by glycosylation and phosphorylation. , 2006, Biochemical and biophysical research communications.
[17] G. Johnson,et al. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. , 2006, Current Alzheimer research.
[18] P. S. St George-Hyslop,et al. Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* , 1997, The Journal of Biological Chemistry.
[19] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] T. Hunter,et al. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.
[21] D. Selkoe,et al. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. , 1994, The Journal of biological chemistry.
[22] T. Iwatsubo,et al. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.
[23] F. Bosetti,et al. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid , 2009, Aging.
[24] N. Milton. Phosphorylated amyloid-beta: the toxic intermediate in alzheimer's disease neurodegeneration. , 2005, Sub-cellular biochemistry.
[25] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[26] H. Levine,et al. Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? , 2008, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[27] N. Milton. Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase. , 2001, Neuroreport.
[28] P. Greengard,et al. Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5 , 2000, Journal of neurochemistry.
[29] Y. Matsuo,et al. Amyloid Oligomer Conformation in a Group of Natively Folded Proteins , 2008, PloS one.
[30] J. Trojanowski,et al. Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism. , 2003, Science of aging knowledge environment : SAGE KE.
[31] S. Sorbi. Molecular genetics of Alzheimer’s disease , 1993, Aging.
[32] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[33] S. Fujii. ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation. , 2004, Journal of pharmacological sciences.
[34] M. Hoch,et al. Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease , 2011, The EMBO journal.
[35] C. Finch,et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] Hui‐Ming Yu,et al. Folding stability of amyloid‐β 40 monomer is an important determinant of the nucleation kinetics in fibrillization , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] A. Bernstein,et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. , 1999, Genes & development.
[38] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[39] H. Levine. The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide. , 2004, Journal of Alzheimer's disease : JAD.
[40] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[41] D. Teplow,et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.
[42] Toshiharu Suzuki,et al. Regulation of Amyloid β-Protein Precursor by Phosphorylation and Protein Interactions* , 2008, Journal of Biological Chemistry.
[43] C. Peers,et al. Modulation of ‘A’-type K+ current by rodent and human forms of amyloid &bgr; protein , 2008, Neuroreport.
[44] M. Higuchi,et al. Metabolism of amyloid-β peptide and Alzheimer's disease , 2005 .
[45] G. Johnson,et al. The role of tau phosphorylation and cleavage in neuronal cell death. , 2007, Frontiers in bioscience : a journal and virtual library.
[46] J. Dornand,et al. Extracellular ATP and cell signalling. , 1992, Biochimica et biophysica acta.
[47] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[48] D. Mann,et al. Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques , 1995, Neuron.
[49] C. Peers,et al. Physiological roles for amyloid beta peptides. , 2006, The Journal of physiology.
[50] E. Masliah,et al. Phosphorylation of Synucleins by Members of the Polo-like Kinase Family* , 2009, The Journal of Biological Chemistry.
[51] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[52] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[54] B. Strooper,et al. The presenilins in Alzheimer's disease--proteolysis holds the key. , 1999, Science.
[55] G. Multhaup,et al. Phosphorylation regulates intracellular trafficking of beta-secretase. , 2001, The Journal of biological chemistry.
[56] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[57] T. Bayer,et al. Concomitant detection of β-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice , 2010, Journal of Chemical Neuroanatomy.
[58] H. Levine,et al. Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key? , 2002, Amino Acids.
[59] Carl W. Cotman,et al. In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.
[60] H. Mantsch,et al. Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro. , 1994, European journal of biochemistry.
[61] A. Delacourte,et al. Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis , 2002, Journal of neurochemistry.
[62] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[63] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[65] Hans-Ulrich Demuth,et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology , 2008, Nature Medicine.
[66] Hans-Ulrich Demuth,et al. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). , 2006, Biochemistry.
[67] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[68] D. Selkoe,et al. Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin , 2008, Neurobiology of Disease.
[69] D. Praticò,et al. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. , 2000, The American journal of medicine.
[70] A. Delacourte,et al. Truncated beta‐amyloid peptide species in pre‐clinical Alzheimer's disease as new targets for the vaccination approach , 2003, Journal of neurochemistry.
[71] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[72] L. Johnson,et al. The effects of phosphorylation on the structure and function of proteins. , 1993, Annual review of biophysics and biomolecular structure.
[73] D. Selkoe,et al. The APP family of proteins: similarities and differences. , 2007, Biochemical Society transactions.
[74] V. Kinzel,et al. Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode. , 1989, The Journal of biological chemistry.
[75] D. Selkoe,et al. The Alzheimer’s Disease-Associated Presenilins Are Differentially Phosphorylated Proteins Located Predominantly within the Endoplasmic Reticulum , 1996, Molecular medicine.
[76] T. Shirasawa,et al. Isomerization and/or racemization at Asp23 of Abeta42 do not increase its aggregative ability, neurotoxicity, and radical productivity in vitro. , 2008, Biochemical and biophysical research communications.
[77] D. Mann,et al. Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. , 1995, Neuron.
[78] A. Negro,et al. The role of phosphorylation in synucleinopathies: focus on Parkinson's disease. , 2010, CNS & neurological disorders drug targets.
[79] M. Higuchi,et al. Metabolism of amyloid-beta peptide and Alzheimer's disease. , 2005, Pharmacology & therapeutics.
[80] B. Hyman,et al. Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy , 2004, Journal of Cell Science.
[81] Bryan Maloney,et al. Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis. , 2011, Gene.
[82] V. Papadopoulos,et al. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[83] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[84] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[85] C. Peers,et al. Physiological roles for amyloid β peptides , 2006 .
[86] M. Emmerling,et al. Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease. , 1998, Biochimica et biophysica acta.
[87] S. Shaltiel,et al. Evidence for an extra-cellular function for protein kinase A , 1993 .
[88] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[89] W. Banks,et al. A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory , 2010 .
[90] T. Shirasawa,et al. Isoaspartate formation and neurodegeneration in Alzheimer's disease. , 2000, Archives of biochemistry and biophysics.
[91] Carl W. Cotman,et al. Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*) , 1995, The Journal of Biological Chemistry.
[92] B. de Strooper,et al. Loss‐of‐function presenilin mutations in Alzheimer disease , 2007, EMBO reports.
[93] U. Müller,et al. The Functions of Mammalian Amyloid Precursor Protein and Related Amyloid Precursor-Like Proteins , 2006, Neurodegenerative Diseases.
[94] A. Barnekow,et al. Ecto-protein kinase activities in normal and transformed cells. , 1986, European journal of cell biology.
[95] B. Bohrmann,et al. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain , 2006, Neuroscience.
[96] M. Sitkovsky,et al. Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? , 1999, Trends in pharmacological sciences.
[97] T. Shirasawa,et al. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease. , 1994, The Tohoku journal of experimental medicine.
[98] G. Dubyak,et al. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. , 1993, The American journal of physiology.
[99] L. Millucci,et al. Conformations and biological activities of amyloid beta peptide 25-35. , 2009, Current protein & peptide science.
[100] C. Cotman,et al. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. , 1995, The Journal of biological chemistry.
[101] A. Goate,et al. Molecular genetics of Alzheimer's disease. , 1993, Archives of neurology.
[102] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[103] George Perry,et al. Signaling effect of amyloid-β42 on the processing of AβPP , 2010, Experimental Neurology.
[104] C. Haass,et al. Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2. , 2000, The Journal of biological chemistry.
[105] V. Papadopoulos,et al. Function of β‐amyloid in cholesterol transport: a lead to neurotoxicity , 2002 .
[106] D. Walsh,et al. Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.
[107] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[108] C. Cotman,et al. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. , 1991, Brain research.
[109] J. Trojanowski,et al. Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease , 1995, Neurobiology of Aging.
[110] G. Burnstock. Purinergic signalling and disorders of the central nervous system , 2008, Nature Reviews Drug Discovery.
[111] Kai Zhang,et al. Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.
[112] V. Kinzel,et al. Induced Release of Cell Surface Protein Kinase Yields CK1- and CK2-like Enzymes in Tandem (*) , 1996, The Journal of Biological Chemistry.
[113] E. Kojro,et al. The non-amyloidogenic pathway: structure and function of alpha-secretases. , 2005, Sub-cellular biochemistry.
[114] T. Shirasawa,et al. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. , 1994, The Journal of biological chemistry.
[115] W. Markesbery,et al. N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.
[116] M. Emmerling,et al. Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. , 1997, Biochemical and biophysical research communications.
[117] D. Sattelle,et al. Alzheimer's disease: insights from Drosophila melanogaster models , 2010, Trends in biochemical sciences.
[118] N. Dale,et al. Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits , 2007, The Journal of physiology.
[119] B. Ghetti,et al. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. , 2005, Biochemistry.
[120] Geoffrey Burnstock,et al. Purinergic signalling in the nervous system: an overview , 2009, Trends in Neurosciences.
[121] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[122] C. Haass,et al. The cell biology of Alzheimer's disease: uncovering the secrets of secretases , 2001, Current Opinion in Neurobiology.
[123] W. Banks,et al. A physiological role for amyloid-beta protein:enhancement of learning and memory. , 2010, Journal of Alzheimer's disease : JAD.
[124] George Perry,et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.
[125] Dominic M. Walsh,et al. Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.
[126] F. Gejyo,et al. Kinetic analysis of amyloid fibril formation. , 1999, Methods in enzymology.
[127] D. Selkoe,et al. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.
[128] H. Mantsch,et al. Synthetic post-translationally modified human Aβ peptide exhibits a markedly increased tendency to form β-pleated sheets in vitro , 1994 .